Business
NuGen Medical Devices names veteran medical executive Ian Heynen as Chief Executive Officer
(NewsDirect) NuGen Medical Devices CEO Ian Heynen joined Steve Darling from Proactive to disc...

About this update from Nugen Medical Devices Inc
[{"type":"text","content":"NuGen Medical Devices names veteran medical executive Ian Heynen as Chief Executive Officer\n \n \n (NewsDirect)\n \n \n NuGen Medical Devices CEO Ian Heynen\njoined Steve Darling from Proactive to discuss his appointment and\nshare some exciting news regarding the company's needle-free\nInsuJet injection device.\n \n \n Heynen\nbrings a wealth of experience to his role as CEO, with a strong track\nrecord in the med-tech industry. He has a history of leadership in\ntechnology-driven organizations, ranging from operational start-ups to\nturnaround situations and high-growth companies.\n \n \n Heynen's expertise includes managing\nP&Ls for both North American and international businesses, with\nmulti-site divisions and gross revenues exceeding $600 million. He is\nknown for driving growth through product innovation and international\nexpansion in both startup and multinational firms.\n \n \n In addition to his appointment, Heynen\nalso shared a significant achievement for NuGen Medical Devices. The\nMexican government has completed the registration of NuGen's\nneedle-free InsuJet injection device as a medical device for sale\nthroughout the country.\n \n \n Furthermore,\nNuGen has a distribution agreement in place with Science-Link, aiming\nto sell approximately 5,000 needle-free injectors in 2024.\n \n \n Looking to 2024, Heynen outlined\nNuGen's plans for both geographical market expansion and a\nstrategic shift towards collaborating with pharma companies and\nhealthcare systems. The goal is to broaden the technology's\nrecognition and accessibility, particularly in Canada, the US, the UK,\nand additional EU markets.\n \n \n The interview showcases NuGen's\ncommitment to revolutionizing medical device technology and improving\npatient experiences worldwide.\n \n \n \n \n \n Contact\nDetails\n \n \n \n Proactive Investors\n \n \n +1 604-688-8158\n \n \n \n [email protected]\n \n \n \n Copyright (c) 2023 TheNewswire - All rights reserved.\n \n \n","length":2485,"tagName":"div"}]